首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Mutation of<Emphasis Type="Italic">gyrA</Emphasis> and<Emphasis Type="Italic">parC</Emphasis> in clinical isolates of<Emphasis Type="Italic">Acinetobacter baumannii</Emphasis> and its relationship with antimicrobial drugs resistance in Taiwan
Authors:Shang-Tao?Chien  Chun-Hsiu?Lin  Jui-Chen?Hsueh  Pei-Ling?Li  Chao-Hsun?Hsu  Shu-Hui?Chang  Hsin-I?Chien  Ren-Jy?Ben  Fu-Hsin?Chang  Email author" target="_blank">Li-Sung?HsuEmail author
Institution:1.Department of Pathology,Kaohsiung Armed Forces General Hospital,Kaohsiung;2.Department of Internal Medicine,Kaohsiung Armed Forces General Hospital,Kaohsiung;3.Department of Biomedical Research,Asia-Pacific Biotech Developing, Inc.,Kaohsiung;4.Institute of Biochemistry and Biotechnology,Chung Shan Medical University,Taichung,Taiwan
Abstract:Acinetobacter baumannii is a species of non fermentative Gram-negative bacteria commonly found in water and soil. This organism was susceptible to most antibiotics in the 1970s. It has now become a major cause of hospital-acquired infections worldwide due to its remarkable propensity to rapidly acquire resistance determinants to a wide range of antibacterial agents. Herein we have determined the mutation frequency of two hot spot residue 83 in gyrA of gyrase and residue 80 in parC of topoisomerase IV and performed a comparative screen the drug resistance ability in 128 clinical isolates ofAcinetobacter baumannii in Taiwan region. Low frequency of mutation was found (11.7%, 11.7%, and 10.2% ingyrA, parC, or both, respectively). Mutation of these sites was not correlated with drug resistance. Our study suggested that mutation ofgyrA andparC may play a minor role in quinolone resistance and other mechanisms may contribute to the drug resistance ofA. Baumannii.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号